top of page
The Professional Network for Healthcare Experts
Viatris wins Japanese approval for Wakix in narcolepsy and obstructive sleep apnoea
Viatris has received Japanese approval for Wakix to treat narcolepsy and excessive daytime sleepiness associated with obstructive sleep apnoea.
nuaxia
Sep 181 min read
FDA approves Orzeyful as first treatment to address the full range of narcolepsy type 1 symptoms
The orexin receptor agonist provides adults with a treatment that targets the underlying loss of orexin signalling rather than managing individual symptoms separately.
nuaxia
Aug 72 min read
FDA approves Orzeyful as first treatment to address the full range of narcolepsy type 1 symptoms
The orexin receptor agonist provides adults with a treatment that targets the underlying loss of orexin signalling rather than managing individual symptoms separately.
nuaxia
Aug 62 min read
bottom of page